rhodamine 123 has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballandonne, C; Bouet, V; Boulouard, M; Claeysen, S; Corvaisier, S; Cresteil, T; Dallemagne, P; Freret, T; Gaven, F; Giannoni, P; Hedou, D; Lecoutey, C; Malzert Fréon, A; Mignani, S; Rochais, C; Since, M | 1 |
| Blessing, K; Kador, PF; Kawada, H; Kiyota, T; Winchester, L; Woolman, T | 1 |
| Newman, SA; Nicolazzo, JA; Pan, Y; Short, JL | 1 |
| Cascorbi, I; Grube, M; Jedlitschky, G; Jucker, M; Kroemer, HK; Krohn, M; Kuhnke, D; Mosyagin, I; Vogelgesang, S; Walker, LC; Warzok, RW | 1 |
| Ahn, YG; Byeon, SR; Jeon, M; Kim, DJ; Kim, HV; Kim, HY; Kim, MS; Kim, YS; Kong, JY | 1 |
5 other study(ies) available for rhodamine 123 and Alzheimer Disease
| Article | Year |
|---|---|
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Chlorocebus aethiops; Cholinesterase Inhibitors; Cognition; COS Cells; Cyclosporine; Drug Design; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Kinetics; Ligands; Mice; Permeability; Piperidines; Receptors, Serotonin, 5-HT4; Rhodamine 123; Serotonin 5-HT4 Receptor Agonists; Solubility; Task Performance and Analysis | 2014 |
Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Fluorescent Dyes; Humans; Matrix Metalloproteinase 2; Mice; Mice, Transgenic; Mitochondria; Neuroblastoma; Quinolones; Rhodamine 123; Tosyl Compounds; Zinc | 2015 |
Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Blotting, Western; Brain; Cell Culture Techniques; Chlorates; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Gene Expression; Humans; Lithium Chloride; Mice; Rhodamine 123; Transfection | 2017 |
MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Cell Compartmentation; Cell Membrane; Endothelial Cells; Extracellular Space; LLC-PK1 Cells; Metabolic Clearance Rate; Peptide Fragments; Peptides; Protein Transport; Rhodamine 123; Swine; Transfection; Transport Vesicles | 2007 |
Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment.
Topics: Administration, Oral; Alzheimer Disease; Aniline Compounds; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Ether-A-Go-Go Potassium Channels; Half-Life; Male; Mice; Mice, Inbred ICR; Stilbenes | 2013 |